Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Aspargo Acquires Bandol Sildenafil Spray.

Document Cited in Related
Vincent

MANews-(C)2009-2022

US-based specialty pharmaceutical company Aspargo Laboratories, Inc has acquired the prescription brand Bandol (sildenafil oral suspension) from Spanish specialty pharmaceutical company Laboratorios Rubio S.A., the company said.

Bandol is indicated for the treatment of erectile dysfunction. Concurrent with the acquisition, Aspargo entered into a distribution agreement with Rubio for the continued marketing and promotion of Bandol in Spain and a license and supply agreement with Farmalider, S.A. (Madrid, Spain) for the supply of Bandol to the Spanish market.

Bandol, offered in a metered dose container that delivers the equivalent of 12.5 mg per actuation, is manufactured in Spain and is prescribed predominantly by primary care physicians and urologists.

Originally licensed by Rubio from Farmalider, a pharmaceutical company dedicated to the research, development, and manufacture of pharmaceutical products, and launched by Rubio in 2020, Bandol is the only sildenafil oral spray currently on the market world-wide.

The Spanish market for Viagra, Cialis, and their generic equivalents was...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT